Embleema builds a patient-driven healthcare blockchain network and in July 2018 launched PatientTruth, a blockchain-based personal health record that lets patients assemble dispersed records and control data sharing via smart contracts. Patients can receive tokens for participating in clinical research, and the system is hosted on a private Ethereum blockchain. The company is positioning a decentralized marketplace for sharing Real World Evidence and clinical data to connect patients, health networks, research centers, and life sciences companies. Embleema emphasizes patient data sovereignty and monetization without third-party data brokers. The company aims to accelerate joint development of blockchain applications for patients and pharmacies and to expand commercial deployment. Embleema’s team includes executives with backgrounds at Harvard Medical School, T‑Systems, Pierre Fabre, iBionext, and Nokia/Withings Digital Health.

Total raised

$4M

Funding rounds

1

Latest round

Series A

Latest activity

Feb 2019